Global Albuterol Sulfate Metered-Dose Inhalers Market Size, Share, and Trends Analysis Report, By Application (Asthma and Chronic Obstructive Pulmonary Disease (COPD)) and By Distribution Channel (Hospital Pharmacies, and Retail Drug Stores), Forecast (2022-2028)

The global Albuterol sulfate metered-dose inhalers market is anticipated to grow at a considerable CAGR 4% during the forecast period (2022-2028). Albuterol sulfate metered-dose inhalers are inhalers containing albuterol sulfate that prevent wheezing and shortness of breath due to various respiratory problems including asthma, and COPD. The major factor attributing to the growth of the global albuterol sulfate metered-dose inhalers market includes the rising prevalence of asthma across the globe. According to the Asthma and Allergy Foundation of America (AAFA), asthma is one of the common respiratory conditions affecting one in every 13 people living in the US alone with around 25 million patients of asthma alone. This represents around 8% of adults and 7% of children in the total population of the US.

In addition, the application of albuterol sulfate metered-dose inhalers is also increasing in the long-term treatment of COPD. According to the report published by the World Health Organization (WHO) in June 2021, the third leading cause of mortality is COPD with a mortality of around 3.23 million people globally in 2019. COPD is a common preventable and treatable chronic lung disease affecting both men and women equally across the globe. Thus, boosting the demand for an albuterol sulfate metered-dose inhaler for the treatment of several symptoms including chronic cough, tiredness, breathlessness, and others due to COPD.

The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, in April 2020, the USFDA approved the generic version of Proventil HFA metered-dose inhaler for the treatment and prevention of bronchospasm. It is the albuterol sulfate metered-dose inhalers of dosage of 90 mcg/inhalation that can be used in patients of age 4 years or above having obstructive airway disease.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Application
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Teva Pharmaceuticals Industries Ltd., Viatris Inc., Apotex Inc., GlaxoSmithKline plc, and Merck Group, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Albuterol sulfate metered-dose inhalers  Market Report by Segment

By Application

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

By Distribution Channel

• Hospital Pharmacies
• Retail Drug Stores